According to Sientra's latest financial reports the company's current EPS (TTM) is -$6.66. In 2022 the company made an earnings per share (EPS) of -$10.56 an increase over its 2021 EPS that were of -$11.40.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$6.66 | -36.93% |
2022 | -$10.56 | -7.37% |
2021 | -$11.40 | -36.31% |
2020 | -$17.90 | -39.53% |
2019 | -$29.60 | -10.3% |
2018 | -$33.00 | -1.2% |
2017 | -$33.40 | 51.82% |
2016 | -$22.00 | -9.47% |
2015 | -$24.30 | 326.63% |
2014 | -$5.70 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Edwards Lifesciences EW | $2.35 | -135.29% | ๐บ๐ธ USA |
iRadimed IRMD | $1.16 | -117.42% | ๐บ๐ธ USA |
Cardiovascular Systems CSII | -$0.97 | -85.44% | ๐บ๐ธ USA |
West Pharmaceutical WST | $7.51 | -212.76% | ๐บ๐ธ USA |